Cited 13 time in
Designing a Novel Functional Peptide With Dual Antimicrobial and Anti-inflammatory Activities via in Silico Methods
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Shin, Min Kyoung | - |
| dc.contributor.author | Lee, Byungjo | - |
| dc.contributor.author | Kim, Seung Tae | - |
| dc.contributor.author | Yoo, Jung Sun | - |
| dc.contributor.author | Sung, Jung-Suk | - |
| dc.date.accessioned | 2023-04-27T12:40:21Z | - |
| dc.date.available | 2023-04-27T12:40:21Z | - |
| dc.date.issued | 2022-04 | - |
| dc.identifier.issn | 1664-3224 | - |
| dc.identifier.issn | 1664-3224 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/3292 | - |
| dc.description.abstract | As spider venom is composed of various bioactive substances, it can be utilized as a platform for discovering future therapeutics. Host defense peptides are great candidates for developing novel antimicrobial agents due to their multifunctional properties. In this study, novel functional peptides were rationally designed to have dual antibacterial and anti-inflammatory activities with high cytocompatibility. Based on a template sequence from the transcriptome of spider Agelena koreana, a series of via in silico analysis were conducted, incorporating web-based machine learning tools along with the alteration of amino acid residues. Two peptides, Ak-N' and Ak-N'm, were designed and were subjected to functional validation. The peptides inhibited gram-negative and gram-positive bacteria by disrupting the outer and bacterial cytoplasmic membrane. Moreover, the peptides down-regulated the expression of pro-inflammatory mediators, tumor necrosis factor-alpha, interleukin (IL)-1 beta, and IL6. Along with low cytotoxicity, Ak-N'm was shown to interact with macrophage surface receptors, inhibiting both Myeloid differentiation primary response 88-dependent and TIR-domain-containing adapter-inducing interferon-beta-dependent pathways of Toll-like receptor 4 signaling on lipopolysaccharide-stimulated THP-1-derived macrophages. Here, we rationally designed functional peptides based on the suggested in silico strategy, demonstrating new insights for utilizing biological resources as well as developing therapeutic agents with enhanced properties. | - |
| dc.format.extent | 16 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Frontiers Media S.A. | - |
| dc.title | Designing a Novel Functional Peptide With Dual Antimicrobial and Anti-inflammatory Activities via in Silico Methods | - |
| dc.type | Article | - |
| dc.publisher.location | 스위스 | - |
| dc.identifier.doi | 10.3389/fimmu.2022.821070 | - |
| dc.identifier.scopusid | 2-s2.0-85128342195 | - |
| dc.identifier.wosid | 000788006300001 | - |
| dc.identifier.bibliographicCitation | Frontiers in Immunology, v.13, pp 1 - 16 | - |
| dc.citation.title | Frontiers in Immunology | - |
| dc.citation.volume | 13 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 16 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Immunology | - |
| dc.relation.journalWebOfScienceCategory | Immunology | - |
| dc.subject.keywordPlus | AMINO-ACID SUBSTITUTION | - |
| dc.subject.keywordPlus | CYTOTOXICITY | - |
| dc.subject.keywordPlus | STABILITY | - |
| dc.subject.keywordPlus | VENOM | - |
| dc.subject.keywordAuthor | transcriptome | - |
| dc.subject.keywordAuthor | in silico analysis | - |
| dc.subject.keywordAuthor | antimicrobial peptide (AMP) | - |
| dc.subject.keywordAuthor | anti-inflammatory peptide (AIP) | - |
| dc.subject.keywordAuthor | TLR4 pathway | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
